Skip to content

Mannkind MNKD Research and development expense

Research and development expense at other companies

Boston Scientific logo
Boston ScientificBSX
$516M+16.5%
Eli Lilly logo
Eli LillyLLY
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
Merit Medical Systems logo
Merit Medical SystemsMMSI
Savara logo
SavaraSVRA
Medtronic logo
MedtronicMDT

Segments

By segment

See full
All Other Segments$17.23M+56.3%

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/E228.5×
P/S3.3×-0.6×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's research and development expense?
Mannkind (MNKD) reported research and development expense of $17.23M in Q1 2026.
How has Mannkind's research and development expense changed year-over-year?
Mannkind's research and development expense increased by 56.3% year-over-year, from $11.02M to $17.23M.
What is the long-term trend for Mannkind's research and development expense?
Over 4 years (2021 to 2025), Mannkind's research and development expense has grown at a 52.4% compound annual growth rate (CAGR), from $12.31M to $66.35M.